摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-<<2-(diethylamino)ethyl>amino>-7-methoxy-4-nitro-9(10H)-acridinone | 99139-89-6

中文名称
——
中文别名
——
英文名称
1-<<2-(diethylamino)ethyl>amino>-7-methoxy-4-nitro-9(10H)-acridinone
英文别名
1-[[2-(diethylamino)ethyl]amino]-7-methoxy-4-nitro-9(10H)-acridinone;1-[2-(diethylamino)ethylamino]-7-methoxy-4-nitro-10H-acridin-9-one
1-<<2-(diethylamino)ethyl>amino>-7-methoxy-4-nitro-9(10H)-acridinone化学式
CAS
99139-89-6
化学式
C20H24N4O4
mdl
——
分子量
384.435
InChiKey
HGCUZKFNPOOGSK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    28
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    99.4
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-<<2-(diethylamino)ethyl>amino>-7-methoxy-4-nitro-9(10H)-acridinone一水合肼 作用下, 以 四氢呋喃 为溶剂, 反应 0.5h, 生成 4-Amino-1-(2-diethylamino-ethylamino)-7-methoxy-10H-acridin-9-one
    参考文献:
    名称:
    Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias
    摘要:
    The synthesis of 8-hydroxy and 8-methoxy analogues of some substituted 5-aminoimidazoacridinones (4) is described. The synthesis was carried out by a three-step sequence from the corresponding 1-chloro-4-nitro-9(10H)-acridinone precursors (1). The annulation of the imidazolo ring onto the aminoacridinone chromophore was accomplished by heating the required aminoacridinone (3) with formic acid or, in the case of 1-methyl derivatives, with N,N-dimethylacetamide. Potent cytotoxic activity against L1210 leukemia, as well as antitumor activity against P388 leukemia in mice, was demonstrated for the 8-hydroxy analogues. The corresponding 8-methoxy derivatives were not cytotoxic. However, in some cases, they showed significant in vivo antileukemic activity.
    DOI:
    10.1021/jm00080a026
  • 作为产物:
    描述:
    1-chloro-7-methoxy-4-nitro-9(10H)-acridinoneN,N-二乙基乙二胺N,N-二甲基甲酰胺 为溶剂, 反应 0.5h, 以92%的产率得到1-<<2-(diethylamino)ethyl>amino>-7-methoxy-4-nitro-9(10H)-acridinone
    参考文献:
    名称:
    Imidazoacridinone derivative compounds and methods for their use
    摘要:
    本发明提供了公式为的IA衍生物化合物:其中变量如本文所述。
    公开号:
    US20100137351A1
点击查看最新优质反应信息

文献信息

  • Imidazoacridinone derivative compounds and methods for their use
    申请人:Assaraf Yehuda G.
    公开号:US20100137351A1
    公开(公告)日:2010-06-03
    The present invention provides IA derivative compounds of the formula: where the variables are described herein.
    本发明提供了公式为的IA衍生物化合物:其中变量如本文所述。
  • Substituted 1-amino-4-nitro-acridinones, pharmaceutical compositions comprising the same and processes for their production
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0145226A2
    公开(公告)日:1985-06-19
    Substituted 1-Amino-4-nitroacridinones of formula as antibacterial and antitumor agents are herein described. Also disclosed are processes for their production and pharmaceutical compositions comprising the new compounds.
    式中的取代的 1-氨基-4-硝基吖啶酮作为抗菌剂和抗肿瘤剂在此被描述。 作为抗菌剂和抗肿瘤剂。此外,还公开了其生产工艺和包含这些新化合物的药物组合物。
  • Imidazoacridines and their antineoplastic use
    申请人:BRITISH TECHNOLOGY GROUP LIMITED
    公开号:EP0502668A1
    公开(公告)日:1992-09-09
    Compounds of formula I in which:    R represents: -OH or -OR′, wherein R′ represents C₁-C₆ alkyl,    R₁a and R₁b, which may be identical or different, represent hydrogen or C₁-C₆ alkyl, unsubstituted or substituted by a hydroxyl, an amino, a N′-alkylamino or a N′,N′-dialkylamino group, such N′-alkyl groups containing 1-4 carbon atoms,    n is 2-5 and    R₂ represents hydrogen, or straight chain C₁₋₄ alkyl, in the form of a free base or a pharmaceutically acceptable acid addition salt or an N-oxide are useful in antineoplastic treatment and prophylaxis, especially of leukaemias.
    式 I 的化合物 其中 R 代表-OH或-OR′,其中R′代表C₁-C₆烷基、 R₁a 和 R₁b 可以相同或不同,代表氢或 C₁-C₆ 烷基,未被羟基、氨基、N′-烷基氨基或 N′,N′-二烷基氨基取代或取代,此类 N′-烷基含有 1-4 个碳原子、 n 为 2-5 R₂ 代表氢或直链 C₁₋₄ 烷基、 以游离碱或药学上可接受的酸加成盐或 N-氧化物的形式存在,可用于抗肿瘤治疗和预防,尤其是白血病。
  • US4626540A
    申请人:——
    公开号:US4626540A
    公开(公告)日:1986-12-02
  • US8470844B2
    申请人:——
    公开号:US8470844B2
    公开(公告)日:2013-06-25
查看更多